CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-02-22 | Aldagen Holdings, LLC 10% owner | Purchase · Warrant (right to buy) | +63,636 | 63,636 | ||
| 2013-02-22 | Aldagen Holdings, LLC 10% owner | Purchase · Warrant (right to buy) | +12,727 | 12,727 | ||
| 2013-02-22 | Aldagen Holdings, LLC 10% owner | Purchase · Warrant (right to buy) | +19,091 | 19,091 | ||
| 2013-02-22 | Kent Richard S Director | Purchase | +14,042 | $0.55 | $8K | 53,934 |
| 2013-02-22 | Kent Richard S Director | Purchase | +307,171 | $0.55 | $169K | 1,179,805 |
| 2013-02-22 | Kent Richard S Director | Purchase | +321,211 | $0.55 | $177K | 1,233,738 |
| 2013-02-22 | Kent Richard S Director | Purchase | +321,213 | $0.55 | $177K | 1,233,740 |
| 2013-02-22 | Kent Richard S Director | Purchase · Warrant (right to buy) | +9,829 | 9,829 | ||
| 2013-02-22 | Kent Richard S Director | Purchase · Warrant (right to buy) | +215,020 | 215,020 | ||
| 2013-02-22 | Kent Richard S Director | Purchase · Warrant (right to buy) | +224,848 | 224,848 | ||
| 2013-02-22 | Kent Richard S Director | Purchase · Warrant (right to buy) | +224,849 | 224,849 | ||
| 2013-02-22 | ROSENDALE MARTIN P Chief Executive Officer | Purchase | +20,000 | $0.53 | $11K | 186,918 |
| 2013-02-22 | JORDEN DAVID EMERSON Director | Purchase | +20,000 | $0.53 | $11K | 6,725,000 |
| 2013-02-21 | JORDEN DAVID EMERSON Director | Purchase | +30,000 | $0.53 | $16K | 6,705,000 |
| 2013-02-19 | DEL GUERCIO JOSEPH Director | Purchase · COMMON STOCK | +356,364 | 550,362 | ||
| 2013-02-19 | DEL GUERCIO JOSEPH Director | Purchase | +509,091 | $0.55 | $280K | 1,143,770 |
| 2013-02-19 | DEL GUERCIO JOSEPH Director | Purchase · COMMON STOCK WARRANT | +356,364 | 520,362 | ||
| 2013-02-19 | JORDEN DAVID EMERSON Director | Purchase · COMMON STOCK WARRANT | +114,286 | 620,110 | ||
| 2013-02-13 | Aldagen Holdings, LLC 10% owner | Other disposition | −557,671 | 12,982,145 | ||
| 2012-09-14 | JORDEN DAVID EMERSON Director | Purchase | +25,000 | $0.89 | $22K | 6,675,000 |
Page 12 of 22 · 436 trades